| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA478276
Max Phase: Preclinical
Molecular Formula: C16H26O3S
Molecular Weight: 298.45
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: C=C1C(=O)S[C@H](CCCCCCCCCC)[C@H]1C(=O)O
Standard InChI: InChI=1S/C16H26O3S/c1-3-4-5-6-7-8-9-10-11-13-14(15(17)18)12(2)16(19)20-13/h13-14H,2-11H2,1H3,(H,17,18)/t13-,14+/m1/s1
Standard InChI Key: HVONHEMPNNBVDK-KGLIPLIRSA-N
Associated Targets(non-human)
Fatty acid synthase 89 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 298.45 | Molecular Weight (Monoisotopic): 298.1603 | AlogP: 4.42 | #Rotatable Bonds: 10 |
| Polar Surface Area: 54.37 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 4.23 | CX Basic pKa: | CX LogP: 5.26 | CX LogD: 2.24 |
| Aromatic Rings: 0 | Heavy Atoms: 20 | QED Weighted: 0.48 | Np Likeness Score: 0.53 |
References
| 1. Wang X, Lin J, Chen Y, Zhong W, Zhao G, Liu H, Li S, Wang L, Li S.. (2009) Novel fatty acid synthase (FAS) inhibitors: design, synthesis, biological evaluation, and molecular docking studies., 17 (5): [PMID:19223187] [10.1016/j.bmc.2009.01.050] |
Source
Source(1):